Latest news
Why InnoCare Pharma (SEHK:9969) Is Up 12.9% After Dual Breakthrough Therapy Wins in Cancer and Autoimmune Disease - And What's Next - simplywall.stsimplywall.st · Mon, 10 Aug 2026 10:52:50 GMTETFs Investing in InnoCare Pharma Ltd. Stocks - TradingViewTradingView · Fri, 07 Aug 2026 11:00:48 GMTInnoCare Pharma (SEHK:9969) Following Breakthrough Therapy News And The Undervalued Narrative - simplywall.stsimplywall.st · Fri, 07 Aug 2026 05:51:49 GMTInnoCare Announces Orelabrutinib in Combination with Mesutoclax Granted Breakthrough Therapy Designation in China - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 02:48:00 GMTBreakthrough Psoriasis Data For Oral TYK2 Drug Might Change The Case For Investing In InnoCare Pharma (SEHK:9969) - simplywall.stsimplywall.st · Wed, 29 Jul 2026 11:22:54 GMTOak Hill Bio merges with RA Capital SPAC; InnoCare’s TYK2 drug hits in Phase 3 - Endpoints NewsEndpoints News · Tue, 28 Jul 2026 07:00:00 GMT